What Is Whipple Surgery?

Many pancreatic cancer patients are diagnosed after the cancer has spread beyond the pancreas, making surgery a risky treatment option. But for those patients whose cancer is localized, surgery may be used to remove the tumor and prevent further spread. When the tumor is confined to the head or neck of the pancreas, the “Whipple” operation (or pancreaticoduodenectomy) is the most common procedure.

pancreatic cancer, Brian Wolpin, Thomas Clancy, Richard Swanson, surgery, whipple

Surgical oncologists Thomas Clancy, MD, (left) and Richard Swanson, MD, work with medical oncologists including Brian Wolpin, MD, (right) to treat patients with pancreatic cancer.

During the Whipple operation, a complex procedure lasting about six hours, surgeons will first check to make sure the tumor has not spread. They then remove the head of the pancreas; the duodenum, part of the small intestine; a portion of the bile duct; the gallbladder; and sometimes part of the stomach and nearby lymph nodes. After removing these internal organs, surgeons connect the remaining pancreas, bile duct, and small intestine so the body can digest food normally.

The Whipple operation requires an experienced team to anticipate and manage the many potential side effects, which may include:

 

  • temporary leak of pancreatic fluid from the pancreatic connection
  • infections
  • bleeding
  • slow emptying from the stomach after eating
  • weight loss
  • change in bowl habits
  • diabetes

 

Dana-Farber nutritionists will often recommend patients eat small, frequent meals after the procedure until the stomach is able to empty itself properly. Patients also require close follow up to monitor for any evidence of diabetes or decreased pancreatic function.

Learn more about treatment for pancreatic cancer, which may also require chemotherapy and radiation therapy, from the Pancreas and Biliary Tumor Center at Dana-Farber/Brigham and Women’s Cancer Center.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber clinicians have been involved in the development of several new agents approved recently for B-cell acu… https://t.co/Oo3SiY79EN
Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.